ATP7B expression is associated with in vitro sensitivity to cisplatin in non-small cell lung cancer.
about
Purinergic signalling and cancerPharmacogenomics of cisplatin sensitivity in non-small cell lung cancerUpregulated expression of FGF13/FHF2 mediates resistance to platinum drugs in cervical cancer cells.Gene expression and single nucleotide polymorphism of ATP7B are associated with platinum-based chemotherapy response in non-small cell lung cancer patients
P2860
ATP7B expression is associated with in vitro sensitivity to cisplatin in non-small cell lung cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
ATP7B expression is associated ...... in non-small cell lung cancer.
@ast
ATP7B expression is associated ...... in non-small cell lung cancer.
@en
type
label
ATP7B expression is associated ...... in non-small cell lung cancer.
@ast
ATP7B expression is associated ...... in non-small cell lung cancer.
@en
prefLabel
ATP7B expression is associated ...... in non-small cell lung cancer.
@ast
ATP7B expression is associated ...... in non-small cell lung cancer.
@en
P2093
P2860
P356
P1433
P1476
ATP7B expression is associated ...... in non-small cell lung cancer.
@en
P2093
Hiroshi Suemizu
Hozumi Matsumoto
Iwao Takanami
Kenji Kawai
Masato Nakamura
Masatoshi Gika
Masayuki Iwazaki
Shunsuke Yamada
Yoshimasa Inoue
P2860
P304
P356
10.3892/OL_00000049
P577
2010-03-01T00:00:00Z